Cannalyze

Company Overview

Snapshot

Founded in February 2019 by Moshe Keva and Erel Kapah, Cannalyze operated with 1–10 employees. The company ceased operations in January 2020.

Business overview

Cannalyze is developing an AI-based database focused on lab-tested cannabis compounds. Its core technology aims to provide consumers, caregivers, growers, and dispensaries with data on product effects. The company serves the cannabis industry, enabling dispensaries to inform customers, providing growers with product feedback, and assisting caregivers in prescribing suitable strains. Cannalyze operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, leveraging artificial intelligence.

Company Intelligence Q&A

What is Cannalyze's primary focus?

Cannalyze is developing an AI-based database to provide data on lab-tested cannabis compounds and their potential effects to consumers, caregivers, growers, and dispensaries.

When was Cannalyze founded?

Cannalyze was founded in February 2019 by Moshe Keva and Erel Kapah.

What is the operational status of Cannalyze?

Cannalyze ceased to operate in January 2020 and is currently non-active.

What markets does Cannalyze aim to serve?

Cannalyze aims to serve consumers, caregivers, growers, and dispensaries within the cannabis industry by providing detailed compound data and product insights.

Who are the founders of Cannalyze?

Cannalyze was co-founded by Moshe Keva and Erel Kapah.